FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Somatropin Injection
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Genentech, Inc (New 03/22/2024)

Company Contact Information:
800-551-2231

Presentation	Posting Date	Related Information
Nutropin AQ, Injection, 10 mg/2 mL (NDC 50242-074-01)	03/22/2024	The decision to discontinue commercial distribution of Nutropin AQ in the United States is a business decision, taken in view of the availability of generic and alternative treatments for patients, and is not related to any quality, safety or efficacy concerns with the product.
Nutropin AQ, Injection, 5 mg/2 mL (NDC 50242-075-01)	03/22/2024	The decision to discontinue commercial distribution of Nutropin AQ in the United States is a business decision, taken in view of the availability of generic and alternative treatments for patients, and is not related to any quality, safety or efficacy concerns with the product.
Nutropin AQ, Injection, 20 mg/2 mL (NDC 50242-076-01)	03/22/2024	The decision to discontinue commercial distribution of Nutropin AQ in the United States is a business decision, taken in view of the availability of generic and alternative treatments for patients, and is not related to any quality, safety or efficacy concerns with the product.